Scynexis Inc (SCYX)

Oct 18, 2025

Is SCYNEXIS Inc. stock ready for a breakoutStop Loss & Stock Portfolio Risk Control - newser.com

Oct 18, 2025

Oct 18, 2025

Why SCYNEXIS Inc. stock appeals to dividend seekersQuarterly Profit Summary & Expert Approved Trade Ideas - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 18, 2025

Is SCYNEXIS Inc. stock a top pick in earnings seasonJuly 2025 Reactions & Scalable Portfolio Growth Methods - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 18, 2025

How SCYNEXIS Inc. stock reacts to Fed rate cutsMarket Growth Summary & Weekly Return Optimization Plans - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 17, 2025

How interest rate cuts could boost SCYNEXIS Inc. stockExit Point & Reliable Price Breakout Alerts - newser.com

Oct 17, 2025

Oct 17, 2025

Why SCYNEXIS Inc. stock remains resilientJuly 2025 Gainers & Safe Entry Momentum Stock Tips - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025

Oct 17, 2025

Statistical indicators supporting SCYNEXIS Inc.’s strengthJuly 2025 Volume & Community Consensus Picks - newser.com

Oct 17, 2025

Oct 17, 2025

How strong is SCYNEXIS Inc. (135A) stock earnings growthProfit Target & Low Risk Investment Opportunities - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025

Oct 17, 2025

Does SCYNEXIS Inc. fit your quant trading modelJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Oct 17, 2025

Oct 16, 2025

Can SCYNEXIS Inc. (135A) stock attract analyst upgradesMarket Trend Review & Risk Managed Investment Strategies - newser.com

Oct 16, 2025

Oct 16, 2025

SCYNEXIS’s (SCYX) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World

Oct 16, 2025

Oct 16, 2025

Building trade automation scripts for SCYNEXIS Inc.Entry Point & Long-Term Capital Growth Strategies - newser.com

Oct 16, 2025

Oct 15, 2025

Key facts: GSK Acquires 3.5M Shares; Settles $22M Dispute with Scynexis - TradingView

Oct 15, 2025

Oct 15, 2025

SCYNEXIS receives $22 million from GSK as MARIO study ends By Investing.com - Investing.com Nigeria

Oct 15, 2025

Oct 15, 2025

What MACD signals say about SCYNEXIS Inc.Weekly Risk Report & Advanced Swing Trade Entry Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com

Oct 15, 2025

Oct 15, 2025

Using R and stats models for SCYNEXIS Inc. forecasting2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

SCYNEXIS, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited Enter into Binding Memorandum of Understanding for Amendment to Exclusive License Agreement - MarketScreener

Oct 15, 2025

Oct 15, 2025

Scynexis to receive $24.3 million from GSK as MARIO study ends per new agreement - Investing.com Nigeria

Oct 15, 2025

Oct 15, 2025

SCYNEXIS receives $22 million from GSK as MARIO study ends - Investing.com

Oct 15, 2025

Oct 15, 2025

SCYNEXIS (SCYX) Secures $22 Million from GlaxoSmithKline Settlem - GuruFocus

Oct 15, 2025

Oct 15, 2025

SCYNEXIS and GSK Amend License Agreement - TipRanks

Oct 15, 2025

Oct 15, 2025

SCYNEXIS to Receive $22 Million Payment from GSK Following MARIO Study Termination - Quiver Quantitative

Oct 15, 2025

Oct 15, 2025

Scynexis and GSK resolve their disagreement related to the restart of the phase 3 MARIO Study - MarketScreener

Oct 15, 2025

Oct 15, 2025

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study - The Manila Times

Oct 15, 2025

Oct 15, 2025

Published on: 2025-10-15 06:26:13 - newser.com

Oct 15, 2025

Oct 14, 2025

SCYNEXIS Inc. stock daily chart insightsPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com

Oct 14, 2025

Oct 14, 2025

Why SCYNEXIS Inc. (135A) stock could rally stronglyJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com

Oct 14, 2025

Oct 14, 2025

Regression analysis insights on SCYNEXIS Inc. performanceMarket Growth Report & Long-Term Capital Growth Ideas - newser.com

Oct 14, 2025